ProCE Banner Activity

Virtual Interaction With Experts: Exploring Novel Therapeutics in Acute Myeloid Leukemia

In this interactive on-demand Webcast, expert hematologists Guillermo Garcia Manero, MD, and Richard Dillon, MD, discuss novel therapeutics in the treatment of acute myeloid leukemia, including the standard of care therapy for patients with AML and incorporation of HDAC inhibitors into their care, and new investigational agents and combinations for AML.

Released: September 03, 2020

Expiration: September 02, 2021

Share

Faculty

Richard Dillon

Richard Dillon, MD

Clinical Senior Lecturer
Department of Medical & Molecular Genetics
Kings Hospital, London
Consultant Haematologist
Department of Haematology
Guys Hospital
London, United Kingdom

Guillermo Garcia-Manero

Guillermo Garcia-Manero, MD

Professor, Division of Cancer Medicine
Chief, Section of Myelodysplastic Syndromes
Division of Cancer Medicine
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

Supporters

Supported by an independent grant from

Helsinn Healthcare SA

Faculty Disclosure

Primary Author

Richard Dillon, MD

Clinical Senior Lecturer
Department of Medical & Molecular Genetics
Kings Hospital, London
Consultant Haematologist
Department of Haematology
Guys Hospital
London, United Kingdom

Richard Dillon, MD, has disclosed that he has received consulting fees from AbbVie, Jazz Pharmaceuticals, Menarini Diagnostics, and Pfizer

Guillermo Garcia-Manero, MD

Professor, Division of Cancer Medicine
Chief, Section of Myelodysplastic Syndromes
Division of Cancer Medicine
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

Guillermo Garcia Manero, MD, has disclosed that he has received consulting fees from Bristol Myers Squibb and Taiho and undertaken contracted research with Bristol Myers Squibb

Staff Disclosure

Staff

Petra Cravens, PhD

Editorial Contributor

Petra Cravens, PhD, has no relevant conflicts of interest to report.

Katie Eustace, MBA

Senior Director, Global Medical Education, Europe

Katie Eustace, MBA, has no relevant conflicts of interest to report.

Kevin Obholz, PhD

Editorial Director, Hematology/Oncology

Kevin Obholz, PhD, has no real or apparent conflicts of interest to report.

Timothy A. Quill, PhD

Senior Managing Editor

Timothy A Quill, PhD, has no relevant conflicts of interest to report.

Justine Stanley, MSc

Editorial Contributor

Justine Stanley, PhD, has no relevant conflicts of interest to report.